Helen D. Sage
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Helen D. Sage has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Helen M. Brown
2 shared publications- John J. Dooley
School of Agricultural Sciences and Practice Royal Agricultural University Cirencester UK
2 shared publications Stephen D. Garrett
2 shared publicationsAdam Waring
Wellcome Centre for Human Genetics, Oxford, United Kingdom (A.R.H., S.S., A.G., A.W., M.F., H.W., K.L.T.).
1 shared publication- Andrew Robert Harper
Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK
1 shared publication Anuj Goel
Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom (A.R.H., A.G., E.O., S.N., M.F., H.W., K.L.T.).
1 shared publication
Latest Publications
- Open Access
- 1 June 2020
- Published by Wolters Kluwer Health in Circulation: Genomic and Precision Medicine
- Vol. 13 (3) , 101-109
Reevaluation of the South Asian MYBPC3 Δ25bp Intronic Deletion in Hypertrophic Cardiomyopathy
Background: The common intronic deletion, MYBPC3 Δ25 , detected in 4% to 8% of South Asian populations, is reported to be associated with cardiomyopathy, with ≈7-fold increased risk of disease in variant carriers. Here, we examine the contribution of MYBPC3 Δ25 to hypertrophic cardiomyopathy (HCM) in a large patient cohort. Methods: Sequence data from 2 HCM cohorts (n=5393) was analyzed to determine MYBPC3 Δ25 frequency and co-occurrence of pathogenic variants in HCM genes. Case-control and haplotype analyses were performed to compare variant frequencies and assess disease association. Analyses were also undertaken to investigate the pathogenicity of a candidate variant MYBPC3 c.1224-52G>A. Results: Our data suggest that the risk of HCM, previously attributed to MYBPC3 Δ25 , can be explained by enrichment of a derived haplotype, MYBPC3 Δ25/ −52 , whereby a small subset of individuals bear both MYBPC3 Δ25 and a rare pathogenic variant, MYBPC3 c.1224-52G>A. The intronic MYBPC3 c.1224-52G>A variant, which is not routinely evaluated by gene panel or exome sequencing, was detected in ≈1% of our HCM cohort. Conclusions: The MYBPC3 c.1224-52G>A variant explains the disease risk previously associated with MYBPC3 Δ25 in the South Asian population and is one of the most frequent pathogenic variants in HCM in all populations; genotyping services should ensure coverage of this deep intronic mutation. Individuals carrying MYBPC3 Δ25 alone are not at increased risk of HCM, and this variant should not be tested in isolation; this is important for the large majority of the 100 million individuals of South Asian ancestry who carry MYBPC3 Δ25 and would previously have been declared at increased risk of HCM.
- 1 June 2020
- Published by Wolters Kluwer Health in Circulation: Genomic and Precision Medicine
- Vol. 13 (3) , 101-109
Open AccessReevaluation of the South Asian MYBPC3 Δ25bp Intronic Deletion in Hypertrophic Cardiomyopathy
Background: The common intronic deletion, MYBPC3 Δ25 , detected in 4% to 8% of South Asian populations, is reported to be associated with cardiomyopathy, with ≈7-fold increased risk of disease in variant carriers. Here, we examine the contribution of MYBPC3 Δ25 to hypertrophic cardiomyopathy (HCM) in a large patient cohort. Methods: Sequence data from 2 HCM cohorts (n=5393) was analyzed to determine MYBPC3 Δ25 frequency and co-occurrence of pathogenic variants in HCM genes. Case-control and haplotype analyses were performed to compare variant frequencies and assess disease association. Analyses were also undertaken to investigate the pathogenicity of a candidate variant MYBPC3 c.1224-52G>A. Results: Our data suggest that the risk of HCM, previously attributed to MYBPC3 Δ25 , can be explained by enrichment of a derived haplotype, MYBPC3 Δ25/ −52 , whereby a small subset of individuals bear both MYBPC3 Δ25 and a rare pathogenic variant, MYBPC3 c.1224-52G>A. The intronic MYBPC3 c.1224-52G>A variant, which is not routinely evaluated by gene panel or exome sequencing, was detected in ≈1% of our HCM cohort. Conclusions: The MYBPC3 c.1224-52G>A variant explains the disease risk previously associated with MYBPC3 Δ25 in the South Asian population and is one of the most frequent pathogenic variants in HCM in all populations; genotyping services should ensure coverage of this deep intronic mutation. Individuals carrying MYBPC3 Δ25 alone are not at increased risk of HCM, and this variant should not be tested in isolation; this is important for the large majority of the 100 million individuals of South Asian ancestry who carry MYBPC3 Δ25 and would previously have been declared at increased risk of HCM.
- 1 September 2005
- Published by Elsevier in Food Control
- Vol. 16 (7) , 601-607
Improved fish species identification by use of lab-on-a-chip technology
- 1 September 2005
- Published by Elsevier in Food Control
- Vol. 16 (7) , 601-607
Improved fish species identification by use of lab-on-a-chip technology
- 31 March 2005
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 53 (9) , 3348-3357
Fish Species Identification Using PCR−RFLP Analysis and Lab-on-a-Chip Capillary Electrophoresis: Application to Detect White Fish Species in Food Products and an Interlaboratory Study
Identification of 10 white fish species associated with U.K. food products was achieved using PCR−RFLP of the mitochondrial cytochrome b gene. Use of lab-on-a-chip capillary electrophoresis for end-point analysis enabled accurate sizing of DNA fragments and identification of fish species at a level of 5% (w/w) in a fish admixture. One restriction enzyme, DdeI, allowed discrimination of eight species. When combined with NlaIII and HaeIII, specific profiles for all 10 species were generated. The method was applied to a range of products and subjected to an interlaboratory study carried out by five U.K. food control laboratories. One hundred percent correct identification of single species samples and six of nine admixture samples was achieved by all laboratories. The results indicated that fish species identification could be carried out using a database of PCR−RFLP profiles without the need for reference materials. Keywords: Capillary electrophoresis; food authenticity; species identification; PCR−RFLP; DNA fingerprinting; lab-on-a-chip; cytochrome b; fish species
- 31 March 2005
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 53 (9) , 3348-3357
Fish Species Identification Using PCR−RFLP Analysis and Lab-on-a-Chip Capillary Electrophoresis: Application to Detect White Fish Species in Food Products and an Interlaboratory Study
Identification of 10 white fish species associated with U.K. food products was achieved using PCR−RFLP of the mitochondrial cytochrome b gene. Use of lab-on-a-chip capillary electrophoresis for end-point analysis enabled accurate sizing of DNA fragments and identification of fish species at a level of 5% (w/w) in a fish admixture. One restriction enzyme, DdeI, allowed discrimination of eight species. When combined with NlaIII and HaeIII, specific profiles for all 10 species were generated. The method was applied to a range of products and subjected to an interlaboratory study carried out by five U.K. food control laboratories. One hundred percent correct identification of single species samples and six of nine admixture samples was achieved by all laboratories. The results indicated that fish species identification could be carried out using a database of PCR−RFLP profiles without the need for reference materials. Keywords: Capillary electrophoresis; food authenticity; species identification; PCR−RFLP; DNA fingerprinting; lab-on-a-chip; cytochrome b; fish species
- Open Access
- 1 January 2005
- Published by SAGE Publications in Primary Dental Care
- Vol. os12 (1) , 5-10
A Comparison of Attitudes and Practices of Gutka Users and Non-users in Chitrakoot, India. A Pilot
Aims and objectives: As part of a student elective, this pilot study aimed at investigating attitudes and practices concerning gutka use in a town in India. It was hoped that information gained would assist in formulating an appropriate health education programme to encourage gutka cessation locally and would provide more information about a habit which is also relevant to some UK South Asian populations. Design and setting: 124 consecutively attending subjects (103 males and 21 females) at a charity-run dental clinic in Chitrakoot, India, were interviewed using a semi-structured questionnaire. Main findings: 57 (46%) of the respondents, of whom there were more males than females (103 v. 21), reported current gutka use. There were no differences between users and non-users by age or educational attainment. Users found gutka ‘helpful’ in relieving tension, aiding concentration, combating bad breath and as a leisure activity. They all cited other family members who were using gutka as compared to only 40% of the gutka non-users. Cancer was mentioned as a harmful outcome of gutka use more frequently by non-users. Of the 57 gutka chewers, 36 also chewed paan with tobacco and 20 smoked cigarettes. Conclusions: Gutka chewing involved almost half of the study population and proportionately more males than females. The habit was endemic within families. Many gutka chewers also smoked, chewed paan or drank alcohol, representing a high-risk behaviour for oral cancer. Proportionately more non-chewers were aware of the link with cancer. There are clear implications for health promotion in India. General dental practitioners in the UK should also be aware of the possibility that this habit is becoming more widely adopted in South Asian communities here, involving young children as well as adults. Research into gutka use is also required in the UK.
- 1 January 2005
- Published by SAGE Publications in Primary Dental Care
- Vol. os12 (1) , 5-10
Open AccessA Comparison of Attitudes and Practices of Gutka Users and Non-users in Chitrakoot, India. A Pilot
Aims and objectives: As part of a student elective, this pilot study aimed at investigating attitudes and practices concerning gutka use in a town in India. It was hoped that information gained would assist in formulating an appropriate health education programme to encourage gutka cessation locally and would provide more information about a habit which is also relevant to some UK South Asian populations. Design and setting: 124 consecutively attending subjects (103 males and 21 females) at a charity-run dental clinic in Chitrakoot, India, were interviewed using a semi-structured questionnaire. Main findings: 57 (46%) of the respondents, of whom there were more males than females (103 v. 21), reported current gutka use. There were no differences between users and non-users by age or educational attainment. Users found gutka ‘helpful’ in relieving tension, aiding concentration, combating bad breath and as a leisure activity. They all cited other family members who were using gutka as compared to only 40% of the gutka non-users. Cancer was mentioned as a harmful outcome of gutka use more frequently by non-users. Of the 57 gutka chewers, 36 also chewed paan with tobacco and 20 smoked cigarettes. Conclusions: Gutka chewing involved almost half of the study population and proportionately more males than females. The habit was endemic within families. Many gutka chewers also smoked, chewed paan or drank alcohol, representing a high-risk behaviour for oral cancer. Proportionately more non-chewers were aware of the link with cancer. There are clear implications for health promotion in India. General dental practitioners in the UK should also be aware of the possibility that this habit is becoming more widely adopted in South Asian communities here, involving young children as well as adults. Research into gutka use is also required in the UK.